Mkts

BioLife Solutions, Inc.

NASDAQ: BLFS
$38.61+1.31 (+3.51%)
As of Oct 4, 8:00 PM ET

Key statistics

Day range
36.9538.83
52-week range
17.8639.76
Today
Open37.16
Previous close38.61
Volume0
Valuation
Market cap1.89B
P/E ratio32.58×
EPS (TTM)1.18
Income & risk
Dividend / yield—
Beta-0.44
Avg volume1.11M
Discussion

BLFS News

Stories mentioning BLFS from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue
Cost of Goods Sold10,0047,254
Gross Profit17,49647,3180.000.0014,80050,0960.000.00
Operating Expenses
Research & Development2,650699.002,7092,7191,439(1,246)1,8932,029
Sales General & Admin
Total Operating Expenses
Operating Income (Loss)27.00629.00(89.00)(16,643)(499.00)542.00(418.00)(1,306)
Interest Income
Interest Expense
Other Expense180.001,183284.00247.00101.00(2.00)97.00146.00
Pretax Income1,2482,643703.00(15,712)285.00469.00(551.00)(5,559)
Tax Provision62.00(173.00)82.00126.0014.0024.00(80.00)1.00
Net Income (Loss)1,18611,070621.00(15,838)(448.00)12,459(1,703)(20,719)
Earnings Per Share (Basic)0.020.230.01(0.33)(0.01)0.27(0.04)(0.45)
Earnings Per Share (Diluted)0.020.230.01(0.33)0.000.27(0.04)(0.45)
Weighted Average Shares Outstanding (Basic)48,45947,75447,92547,79847,13546,06746,17546,004
Weighted Average Shares Outstanding (Diluted)49,24848,64548,72447,79848,36846,06746,17546,004

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About BLFS

BioLife Solutions, Inc. (NASDAQ: BLFS) is a stock listed on the Nasdaq Stock Market under the ticker symbol BLFS. It last traded at $38.61 (Oct 4, 2026, 8:00 PM ET), up 3.5% on the day. That gives BioLife Solutions a market capitalisation of $1.9B and a price-to-earnings ratio of 32.6.

Over the past 52 weeks BLFS has traded between $17.86 and $39.76.

Net income for the quarter ended Mar 31, 2026 was $1.2M.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026—$1.2M
Dec 31, 2025—$11.1M
Sep 30, 2025—$621.0K
Jun 30, 2025—-$15.8M

From BioLife Solutions’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…